TENOFOVIR DISOPROXIL FUMARATE 300 mg + EFAVIRENZ 600 mg + EMTRICITABINE 200 mg (Trustiva) x 30 Tablets

Uses of TENOFOVIR DISOPROXIL FUMARATE/EFAVIRENZ/EMTRICITABINE

• Treats HIV-1 infection
• Used as combination antiretroviral therapy (ART)
• Helps reduce the HIV viral load
• Supports immune-system function
• Helps prevent the progression of HIV infection

Benefits of TENOFOVIR DISOPROXIL FUMARATE/EFAVIRENZ/EMTRICITABINE

• Combines three antiviral medicines in one tablet
• Helps suppress HIV replication
• May help improve or maintain CD4 cell counts
• Supports long-term viral control
• Provides convenient once-daily dosing

How Does TENOFOVIR DISOPROXIL FUMARATE/EFAVIRENZ/EMTRICITABINE Work?

Tenofovir disoproxil fumarate, efavirenz, and emtricitabine work together by blocking the reverse transcriptase enzyme that HIV needs to copy its genetic material. Tenofovir and emtricitabine are nucleoside and nucleotide reverse transcriptase inhibitors, while efavirenz is a non-nucleoside reverse transcriptase inhibitor. Together, they prevent viral replication, reduce the amount of HIV in the body, and help protect the immune system.

Side Effects

• Dizziness
• Headache
• Nausea
• Diarrhoea
• Fatigue
• Sleep disturbances
• Skin rash
• Abnormal or vivid dreams

Precautions

• Use only under the supervision of a healthcare provider.
• Take the medicine regularly and avoid missing doses to reduce the risk of drug resistance.
• Inform your doctor if you have liver disease, kidney disease, hepatitis B infection, or a history of mental health conditions.
• Regular monitoring of kidney function, liver function, HIV viral load, and CD4 cell counts may be required.
• Tell your healthcare provider about all medicines and supplements you are taking to help prevent drug interactions.
• Inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding before starting treatment.
• Do not stop treatment without medical advice, as HIV infection may worsen or hepatitis B may flare if present.